EPTQ S100 is a refined hyaluronic acid dermal filler developed for practitioners working in superficial and delicate facial areas where precision, control, and subtlety are required. As part of the EPTQ filler range, S100 is positioned as a low-density formulation intended for fine lines, early volume loss, and soft tissue refinement rather than structural augmentation. The gel has been engineered to integrate smoothly into superficial tissue layers, making it appropriate for treatments where minimal product visibility and controlled distribution are essential. Its balanced rheological profile allows for even placement while maintaining flexibility within dynamic facial areas. EPTQ S100 is commonly selected for periorbital treatments, fine wrinkles, and soft contour refinement, particularly in patients with thinner skin or early signs of ageing. The inclusion of lidocaine supports patient comfort without compromising injection control. With a 1.1ml syringe volume, EPTQ S100 offers flexibility for tailored treatment planning while maintaining consistency across multiple facial zones. Results are gradual and subtle, aligning with practitioner-led aesthetic outcomes rather than overt volumisation. How It Works EPTQ S100 uses cross-linked hyaluronic acid to attract and retain moisture within the superficial dermis. Once placed, the gel integrates into the tissue to support hydration and soft filling of fine lines, improving skin smoothness and contour continuity without excessive projection. Key Benefits Supports subtle correction of fine lines Suitable for superficial and delicate treatment areas Smooth gel texture for controlled injection Low-density formulation for natural integration Lidocaine included for improved patient comfort